LPOXY Therapeutics
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.lpoxy.comRevenue
$7.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About LPOXY Therapeutics
LPOXY Therapeutics is focused on developing an orally administered capsule that delivers oxygen directly to the bowel, aimed at preventing antibiotic-induced colitis and aiding those with inflammatory bowel diseases. Their innovative approach addresses a significant public health threat, particularly C. difficile colitis, which affects nearly half a million Americans annually. The company emphasizes clinically validated efficacy and targeted prevention without systemic disruption. LPOXY Therapeutics is dedicated to utilizing the healing properties of oxygen to protect individuals from superinfections related to antibiotic use.Explore more
LPOXY Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LPOXY Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if LPOXY Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if LPOXY Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once LPOXY Therapeutics has new funding data
Check out if LPOXY Therapeutics is spiking on competitors!
Product Launch: Get notified when LPOXY Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at LPOXY Therapeutics
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on LPOXY Therapeutics recently announced quarterly report
LPOXY Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined LPOXY Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to LPOXY Therapeutics
Compare insights from companies similar to LPOXY Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
LPOXY Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
LPOXY Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about LPOXY Therapeutics.
LPOXY Therapeutics Tech Stack
A closer look at the technologies used by LPOXY Therapeutics
LPOXY Therapeutics News & Media
LPOXY Initiates $28M Series A Financing with 5 Horizons Ventures to Fund STOP-Cdiff Pivotal Trial
Proceeds will fund the registrational STOP-Cdiff (SIDIPREV™ Trial On Prevention of C. difficile Infections) trial for SIDIPREV™, positioned to become the first prevention against C. difficile, a deadly infection that claims 80 U.S. lives daily and lacks any approved preventive therapy....LPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy
PLATTE CITY, Mo., Jan. 3, 2025 /PRNewswire/ -- LPOXY Therapeutics, Inc. ("LPOXY"), a clinical-stage biopharmaceutical company focused on innovative therapies for infectious disease prevention, announced today that it has signed a term sheet to acquire selected assets from Xeno Biosciences...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LPOXY Therapeutics
Sign Up For FreeTo access detailed company insights
LPOXY Therapeutics is focused on developing an orally administered capsule that delivers oxygen directly to the bowel, aimed at preventing antibiotic-induced colitis and aiding those with inflammatory bowel diseases. Their innovative approach addresses a significant public health threat, particularly C. difficile colitis, which affects nearly half... Read More
